Neutralization of Muscarinic Receptor Autoantibodies by Intravenous Immunoglobulin in Sjögren Syndrome
- 1 April 2005
- journal article
- Published by Elsevier in Human Immunology
- Vol. 66 (4) , 411-416
- https://doi.org/10.1016/j.humimm.2005.01.020
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Passive transfer of Sjögren's syndrome IgG produces the pathophysiology of overactive bladderArthritis & Rheumatism, 2004
- Detection of anti–type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assayArthritis & Rheumatism, 2004
- Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmissionArthritis & Rheumatism, 2003
- Parasympathetic nervous system dysfunction in primary Sjögren's syndromeAnnals of the Rheumatic Diseases, 2003
- Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjögren’s syndromeNeurology, 2003
- Fibrosis regression induced by intravenous gammaglobulin treatmentAnnals of the Rheumatic Diseases, 2003
- Antibody-mediated gastrointestinal dysmotility in sclerodermaGastroenterology, 2002
- The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseasesRheumatology, 2002
- Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndromeArthritis & Rheumatism, 2000
- Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren’s syndromeClinical and Experimental Immunology, 1996